Change of FA, %
|
Study 1 Echium oil (n = 59)
|
Study 2 Linseed oil mixture (n = 59)
|
Treatment effect EO vs. LO P2
|
Control groups
|
---|
Fish oil (n = 19)
|
Olive oil (n = 18)
|
---|
Plasma
| | | | | | |
n-3 PUFA
|
ALA
|
230 ± 13b†
|
314 ± 20a†
|
0.001
|
−8 ± 4c
|
14 ± 5c†
|
|
SDA
|
789 ± 69a†
|
159 ± 13b†
|
<0.001
|
59 ± 19b†
|
22 ± 14b
|
|
ETA
|
406 ± 32a†
|
124 ± 10b†
|
<0.001
|
53 ± 12b†
|
27 ± 10b†
|
|
EPA
|
168 ± 8b†
|
67 ± 6c†
|
<0.001
|
646 ± 75a†
|
4 ± 6d
|
|
DPA
|
68 ± 4b†
|
31 ± 3c†
|
<0.001
|
113 ± 13a†
|
−1 ± 2d
|
|
DHA
|
−3 ± 3b
|
−11 ± 2b†
|
0.008
|
39 ± 8a†
|
−5 ± 3b
|
n-6 PUFA
|
LA
|
−9 ± 1b†
|
3 ± 1a†
|
<0.001
|
−13 ± 2b†
|
−8 ± 1b†
|
|
GLA
|
276 ± 23a†
|
−11 ± 3b†
|
<0.001
|
−16 ± 4b†
|
7 ± 6b
|
|
DGLA
|
67 ± 5a†
|
−10 ± 2bc†
|
<0.001
|
−26 ± 4c†
|
6 ± 3b
|
|
AA
|
14 ± 2a†
|
−1 ± 2b
|
<0.001
|
3 ± 3ab
|
0 ± 3b
|
|
22:5n-6
|
−20 ± 3b†
|
−9 ± 3b†
|
0.006
|
−38 ± 7b†
|
12 ± 5a
|
RBC
| | | | | | |
n-3 PUFA
|
ALA
|
156 ± 32b†
|
201 ± 9a†
|
<0.001
|
−12 ± 5c
|
8 ± 3c†
|
|
SDA
|
405 ± 54a†
|
135 ± 22b†
|
<0.001
|
6 ± 13c
|
49 ± 35b
|
|
ETA
|
243 ± 22a†
|
106 ± 7b†
|
<0.001
|
24 ± 6c
|
9 ± 4c
|
|
EPA
|
85 ± 12b†
|
32 ± 4c†
|
<0.001
|
351 ± 35a†
|
−10 ± 3d†
|
|
DPA
|
32 ± 8b†
|
12 ± 2c†
|
<0.001
|
75 ± 16a†
|
−4 ± 2d
|
|
DHA
|
−4 ± 2b†
|
−10 ± 2b†
|
0.15
|
10 ± 9a
|
−9 ± 2b†
|
n-6 PUFA
|
LA
|
11 ± 3a
|
1 ± 1b
|
<0.001
|
−11 ± 4b
|
−4 ± 1b†
|
|
GLA
|
144 ± 16a†
|
0 ± 4b
|
<0.001
|
1 ± 2b
|
7 ± 6b
|
|
DGLA
|
48 ± 9a†
|
−5 ± 1b†
|
<0.001
|
−15 ± 3b
|
3 ± 1b
|
|
AA
|
17 ± 3a†
|
−1 ± 1b
|
<0.001
|
2 ± 4b
|
0 ± 1b
|
|
22:5n-6
|
−2 ± 4a
|
−4 ± 1a†
|
0.43
|
−29 ± 5b†
|
6 ± 2a
|
PBMC
| | | | | | |
n-3 PUFA
|
ALA
|
147 ± 20b†
|
368 ± 28a†
|
<0.001
|
70 ± 43bc
|
13 ± 8c
|
|
SDA
|
424 ± 78a†
|
103 ± 34b
|
<0.001
|
−2 ± 24b
|
47 ± 45b
|
|
ETA
|
388 ± 35a†
|
81 ± 5b†
|
<0.001
|
38 ± 6b†
|
27 ± 19b
|
|
EPA
|
97 ± 9b†
|
45 ± 5c†
|
0.005
|
564 ± 57a†
|
−1 ± 4d
|
|
DPA
|
42 ± 5b†
|
27 ± 2c†
|
0.006
|
94 ± 8a†
|
3 ± 2c
|
|
DHA
|
−20 ± 3b†
|
−15 ± 1b†
|
0.12
|
2 ± 5a
|
−4 ± 2ab
|
n-6 PUFA
|
LA
|
8 ± 2a
|
5 ± 1a
|
0.42
|
6 ± 3a
|
−7 ± 2b†
|
|
GLA
|
128 ± 14a†
|
−1 ± 4b
|
<0.001
|
12 ± 15b
|
7 ± 4b
|
|
DGLA
|
47 ± 17a†
|
−1 ± 1b†
|
<0.001
|
−15 ± 3b†
|
6 ± 2b
|
|
AA
|
−2 ± 3a
|
−2 ± 1a†
|
0.92
|
−10 ± 2b†
|
2 ± 1a
|
|
22:5n-6
|
−17 ± 6a†
|
−8 ± 2a†
|
0.17
|
−48 ± 3b†
|
8 ± 4a
|
-
1Values are means ± SEM; adjusted means not shown. Change is from day 0 to day 56. EO echium oil, ETA 20:4n-3, eicosatetraenoic acid, LO linseed oil mixture, RBC red blood cells, PBMC peripheral blood mononuclear cells. P values were analyzed using the generalized linear mixed model ANCOVA with sex, age, BMI, baseline value as covariates
-
2
P values for the treatment effect including only EO and LO groups
-
abcMeans with different superscript letters are significantly different between all treatments (P ≤ 0.05)
-
†Within one oil treatment, means are significantly different between day 0 and day 56 (repeated measures; P ≤ 0.05)